Superfluous damaged mitochondria further lead to ROS overproduction, affect mitophagy due to overburdened workload, and finally aggravate the decline of cell function
A friend who works in aesthetics mentioned GHK-Cu as something worth researching
The current generation of GLP-1 receptor agonists includes: Semaglutide (weekly subcutaneous injection or oral formulation) Liraglutide (daily subcutaneous injection) Tirzepatide (dual GLP-1/GIP receptor agonist, weekly subcutaneous injection) Each of these GLP-1 agents carries a distinct pharmacological profile, and the optimal choice depends on a patients clinical history, metabolic risk factors, and therapeutic goals a determination best made in consultation with a physician experienced in metabolic and longevity medicine
Before Starting Starting GLP-1 therapy is not a decision to be taken lightly
Clinically, such reactions may present as erythema, pruritus, and eczematous eruptions localised to the areas where the sunscreen was applied